Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of jaundice and liver diseases, technological advancements in bilirubin blood testing, and increasing incidence of preterm births.
The bilirubin blood test market is segmented as below:
By End-user
- Infants
- Adults
By Product Type
- Instruments
- Consumables
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bilirubin blood test market covers the following areas:
- Bilirubin blood test market sizing
- Bilirubin blood test market forecast
- Bilirubin blood test market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global bilirubin blood test market: Abbott Laboratories, Advanced Instruments LLC, ALLMEDTECH, AMETEK Inc., Anamol Laboratories Pvt. Ltd., BIOGENIX Inc. Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Dragerwerk AG and Co. KGaA, ELITechGroup SAS, F. Hoffmann La Roche Ltd., GINEVRI Srl, Jaiprakash Associates Ltd., Koninklijke Philips N.V., Mega Lab SA, Merck KGaA, Micro Lab Instruments, Randox Laboratories Ltd., Siemens AG, Teco Diagnostics, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing demand for non-invasive blood bilirubin procedures.'
According to the report, one of the major drivers for this market is the increasing prevalence of jaundice and liver diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Advanced Instruments LLC
- ALLMEDTECH
- AMETEK Inc.
- Anamol Laboratories Pvt. Ltd.
- BIOGENIX Inc. Pvt. Ltd.
- DiaSys Diagnostic Systems GmbH
- Dragerwerk AG and Co. KGaA
- ELITechGroup SAS
- F. Hoffmann La Roche Ltd.
- GINEVRI Srl
- Jaiprakash Associates Ltd.
- Koninklijke Philips N.V.
- Mega Lab SA
- Merck KGaA
- Micro Lab Instruments
- Randox Laboratories Ltd.
- Siemens AG
- Teco Diagnostics
- Thermo Fisher Scientific Inc.